All Stories

  1. Patient with cancer and cardiac disease.
  2. 2015 update on the diagnosis and management of neoplastic pericardial disease
  3. Systemic chemotherapy in combination with pericardial window has better outcomes in malignant pericardial effusions
  4. Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients' heart?
  5. DRainage Or Pericardiocentesis alone for recurrent nonmalignant, nonbacterial pericardial effusions requiring intervention
  6. Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk
  7. Role of hypertension on new onset congestive heart failure in patients receiving trastuzumab therapy for breast cancer
  8. Oxaliplapin and Capecitabine (XELOX) Based Chemotherapy in the Treatment of Metastatic Colorectal Cancer: The Right Choice in Elderly Patients
  9. Which is the Best Approach to Prevent Relapses after Drainage of Neoplastic Pericardial Effusion? A Multi Center Observational Study
  10. Cardioncology, oncocardiology. Are we barking up the wrong tree?
  11. Massive myocardial infiltration by HIV-related non-Hodgkin lymphoma
  12. Systemic Therapy, Radiotherapy, and Cardiotoxicity
  13. Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)
  14. Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a multicenter cohort analysis
  15. Administration of Angiotensin-Converting Enzyme Inhibitors and  -Blockers During Adjuvant Trastuzumab Chemotherapy for Nonmetastatic Breast Cancer: Marker of Risk or Cardioprotection in the Real World?
  16. Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
  17. Diagnosis and management of neoplastic pericardial effusion
  18. Capecitabine (and 5 Fluorouracil) Cardiotoxicity. Metabolic Considerations
  19. Epidemiology, diagnosis and therapy of neoplastic pericarditis
  20. Neoplastic pericardial disease in lung cancer: Impact on outcomes of different treatment strategies. A multicenter study
  21. Three-dimensional imaging of anomalous origin of the right coronary artery in a young athlete
  22. Approccio cardiologico al paziente sottoposto a trattamento antitumorale. Documento primo
  23. Medical therapy of pericardial diseases
  24. Capecitabine cardiac toxicity presenting as effort angina: a case report
  25. Neoplastic pericardial disease: Old and current strategies for diagnosis and management
  26. Aetiological diagnosis in acute and recurrent pericarditis: when and how
  27. 1172 Prevalence of pericardial effusion in an HIV-infected population
  28. 1182 Anthracycline chemotherapy in the elderly: an echocardiographic study
  29. Severe ventricular dysrhythmias and silent ischemia during infusion of the antimetabolite 5-fluorouracil and cis-platin
  30. 281 Anthracycline-induced cardiomyopathy: characteristics and outcome
  31. 891 Reliability of a new simplified echocardiographic index in assessing the effective orifice area of bioprosthetic aortic valves
  32. Self-management of Oral Anticoagulants by Patients with Atrial Fibrillation: How Effective and Safe Is It?
  33. Coronary vasospasm as a cause of effort-related myocardial ischemia during low-dose chronic continuous infusion of 5-fluorouracil
  34. Local chemotherapy for neoplastic pericardial effusion
  35. Pharmacokinetic and pharmacodynamic effects of high-dose continuous intravenous verapamil infusion
  36. Pacing from Unconventional Sites: Who, When and Why?
  37. Isolated First-Degree Atrioventricular Block: A New Indication for Dual-Chamber Pacing?
  38. Relation of right ventricular morphology and function in pectus excavatum to the severity of the chest wall deformity
  39. Effect of atrial fibrillation on pulmonary venous flow patterns: transoesophageal pulsed Doppler echocardiographic study
  40. Diagnosis of heart tumours by transoesophageal echocardiography: a multicentre study in 154 patients
  41. Echocardiographic prediction of the final event in patients dying of acute myocardial infarction
  42. Role of transesophageal echocardiography in evaluation of pulmonary venous obstruction by paracardiac neoplastic masses
  43. Usefulness of transesophageal echocardiography in evaluation of paracardiac neoplastic masses
  44. Quantification of Mitral Regurgitation: Comparison Between Transthoracic and Transesophageal Color Doppler Flow Mapping
  45. Familial dilated cardiomyopathy: a transverse and longitudinal clinical and echocardiographic study
  46. Sensitivity and Specificity of Electrocardiographic ST-T Changes as Markers of Neoplastic Myocardial Infiltration
  47. Echocardiographic findings of left ventricular hypertrophy and normalization of parameters of left ventricular function in patients with previous evidence of dilated and poorly contracting left ventricle and coexisting systemic hypertension
  48. Two‐dimensional and Doppler Echocardiographic Documentation of Appearance and Progression of Carcinoid Heart Disease
  49. Secondary neoplastic infiltration of the myocardium diagnosed by two-dimensional echocardiography in seven cases with anatomic confirmation
  50. Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effusion